GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 integrase with a non-catayltic site inhibitor

Analyse Crystal structure of HIV-1 integrase with a non-catayltic site inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4E1N
Type
protein
Length
146 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 integrase
UniProt
P12497
Ligands
TQX
Pockets
1 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 integraseprotein14649% helix, 20% strandP12497

Ligands and binding sites

  • TQX · (2S)-tert-butoxy[4-(8-fluoro-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methylquinolin-3-yl]ethanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.380.7917empty

Modifications

Observed in the structure: 2 modified (nonstandard).

Compared structures

  • 4E1N · Crystal Structure of HIV-1 Integrase with a non-catayltic site inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.